Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Angeli A., Frajria R., De Paoli R., Fonzo D., Ceresa F. Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man. Clin Pharmacol Ther. 1978 Jan;23(1):47–53. doi: 10.1002/cpt197823147. [DOI] [PubMed] [Google Scholar]
- Chakraborty J., English J., Marks V., Dumasia M. C., Chapman D. J. A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method. Br J Clin Pharmacol. 1976 Oct;3(5):903–906. doi: 10.1111/j.1365-2125.1976.tb00645.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DAY W. A. Endometriosis involving the rectum and rectosigmoid. Rocky Mt Med J. 1962 May;59:38–40. [PubMed] [Google Scholar]
- Henderson R. G., Wheatley T., English J., Chakraborty J., Marks V. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone. Br Med J. 1979 Jun 9;1(6177):1534–1536. doi: 10.1136/bmj.1.6177.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NICHOLS T., NUGENT C. A., TYLER F. H. DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS. J Clin Endocrinol Metab. 1965 Mar;25:343–349. doi: 10.1210/jcem-25-3-343. [DOI] [PubMed] [Google Scholar]
- Poley G. E., Jr, Shively C. A., Vesell E. S. Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them. Clin Pharmacol Ther. 1978 Dec;24(6):726–732. doi: 10.1002/cpt1978246726. [DOI] [PubMed] [Google Scholar]
- Segre E. J., Klaiber E. L. Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity. Calif Med. 1966 May;104(5):363–365. [PMC free article] [PubMed] [Google Scholar]
- Tanner A., Bochner F., Caffin J., Halliday J., Powell L. Dose-dependent prednisolone kinetics. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):571–578. doi: 10.1002/cpt1979255part1571. [DOI] [PubMed] [Google Scholar]
- Uribe M., Schalm S. W., Summerskill W. H., Go V. L. Oral prednisone for chronic active liver disease: dose responses and bioavailability studies. Gut. 1978 Dec;19(12):1131–1135. doi: 10.1136/gut.19.12.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vesell E. S., Shively C. A., Passananti G. T. Temporal variations of antipyrine half-life in man. Clin Pharmacol Ther. 1977 Dec;22(6):843–852. doi: 10.1002/cpt1977226843. [DOI] [PubMed] [Google Scholar]